{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:44:09Z","timestamp":1791265449616,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1650,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/mt.2011.276","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T16:10:10Z","timestamp":1324397410000},"page":"749-758","source":"Crossref","is-referenced-by-count":250,"title":["The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers"],"prefix":"10.1016","volume":"20","author":[{"given":"Kelley A","family":"Parato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J","family":"Breitbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Le Boeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Storbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ilkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Simon","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Falls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femina","family":"Kanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Evgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Ho","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C","family":"Vanderhyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H","family":"Kirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.276_bib1","first-page":"13","article-title":"Diplomatic immunity: turning a foe into an ally","volume":"11","author":"Parato","year":"2009","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.2011.276_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro1927","article-title":"Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded","volume":"6","author":"Cattaneo","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1038\/mt.2011.276_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1535-6108(03)00170-3","article-title":"Getting oncolytic virus therapies off the ground","volume":"4","author":"Bell","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1038\/mt.2011.276_bib4","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14712598.8.9.1381","article-title":"Development of targeted oncolytic virotherapeutics through translational research","volume":"8","author":"Liu","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/mt.2011.276_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncponc0736","article-title":"Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress","volume":"4","author":"Liu","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1038\/mt.2011.276_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/77558","article-title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","volume":"6","author":"Stojdl","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/mt.2011.276_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1038\/mt.2011.276_bib8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","article-title":"Reovirus therapy of tumors with activated Ras pathway","volume":"282","author":"Coffey","year":"1998","journal-title":"Science"},{"key":"10.1038\/mt.2011.276_bib9","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI9871","article-title":"Reovirus as a novel oncolytic agent","volume":"105","author":"Norman","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2011.276_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"key":"10.1038\/mt.2011.276_bib11","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/80474","article-title":"An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy","volume":"6","author":"Heise","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/mt.2011.276_bib12","first-page":"4656","article-title":"Intraperitoneal therapy of ovarian cancer using an engineered measles virus","volume":"62","author":"Peng","year":"2002","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.276_bib13","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood.V97.12.3746","article-title":"Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice","volume":"97","author":"Grote","year":"2001","journal-title":"Blood"},{"key":"10.1038\/mt.2011.276_bib14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm0995-938","article-title":"Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas","volume":"1","author":"Mineta","year":"1995","journal-title":"Nat Med"},{"key":"10.1038\/mt.2011.276_bib15","first-page":"3963","article-title":"Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant","volume":"54","author":"Mineta","year":"1994","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.276_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrc2545","article-title":"Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer","volume":"9","author":"Kirn","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2011.276_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2011.276_bib18","doi-asserted-by":"crossref","first-page":"17517","DOI":"10.1073\/pnas.0909376106","article-title":"Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry","volume":"106","author":"Laliberte","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.276_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/sj.cgt.7700066","article-title":"Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma","volume":"6","author":"Mastrangelo","year":"1999","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mt.2011.276_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ymthe.2006.05.008","article-title":"Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF","volume":"14","author":"Kim","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.276_bib21","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.276_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(08)70107-4","article-title":"Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial","volume":"9","author":"Park","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1038\/mt.2011.276_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10358","article-title":"Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans","volume":"477","author":"Breitbach","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2011.276_bib24","first-page":"8751","article-title":"Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes","volume":"61","author":"McCart","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.276_bib25","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1172\/JCI32727","article-title":"Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963","volume":"117","author":"Thorne","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2011.276_bib26","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1371\/journal.pmed.0040353","article-title":"Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus","volume":"4","author":"Kirn","year":"2007","journal-title":"PLoS Med"},{"key":"10.1038\/mt.2011.276_bib27","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/gt.2008.82","article-title":"Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus","volume":"15","author":"Foloppe","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.276_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00438-009-0475-1","article-title":"The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation","volume":"282","author":"Zhang","year":"2009","journal-title":"Mol Genet Genomics"},{"key":"10.1038\/mt.2011.276_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-1-4615-5381-6_90","article-title":"Thymidine kinase expression. A marker for malignant cells","volume":"431","author":"Hengstschl\u00e4ger","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/mt.2011.276_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.virol.2005.06.049","article-title":"Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread","volume":"341","author":"Luker","year":"2005","journal-title":"Virology"},{"key":"10.1038\/mt.2011.276_bib31","first-page":"1389","article-title":"Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer","volume":"63","author":"Connolly","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.276_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI200523220","article-title":"Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction","volume":"115","author":"Yang","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2011.276_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/313491a0","article-title":"Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor","volume":"313","author":"Brown","year":"1985","journal-title":"Nature"},{"key":"10.1038\/mt.2011.276_bib34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0167-5699(00)01632-7","article-title":"Soluble chemokine binding proteins are also encoded by herpesviruses","volume":"21","author":"Alcami","year":"2000","journal-title":"Immunol Today"},{"key":"10.1038\/mt.2011.276_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2010.11.006","article-title":"Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa)","volume":"89","author":"Langhammer","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1038\/mt.2011.276_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","article-title":"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","volume":"317","author":"Buller","year":"1985","journal-title":"Nature"},{"key":"10.1038\/mt.2011.276_bib37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1038\/mt.2011.276_bib38","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","article-title":"Pancreatic cancer","volume":"363","author":"Li","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/mt.2011.276_bib39","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1371\/journal.pmed.0020017","article-title":"KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med"},{"key":"10.1038\/mt.2011.276_bib40","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1046\/j.1523-1747.2003.12559.x","article-title":"Mutations of the BRAF gene in benign and malignant melanocytic lesions","volume":"121","author":"Yazdi","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2011.276_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc2645","article-title":"Genetic prognostic and predictive markers in colorectal cancer","volume":"9","author":"Walther","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2011.276_bib42","first-page":"456","article-title":"Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitors","volume":"37","author":"Giaccone","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1038\/mt.2011.276_bib43","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2011.276_bib44","first-page":"813","article-title":"Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors","volume":"61","author":"Douglas","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.276_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jnci\/81.8.577","article-title":"New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity","volume":"81","author":"Weislow","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/mt.2011.276_bib46","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1038\/mt.2011.276_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616305391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616305391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T01:19:52Z","timestamp":1593393592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616305391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1525001616305391"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.276","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}